SCHEMBL31307281

SCHEMBL31307281

CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O

nearest known ligand 0.66

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.58
▸ NTSR2 O95665 5/20 0.56
▸ NTSR1 P30989 5/20 0.56
▸ SORT1 Q99523 4/20 0.56
▸ OPRM1 P35372 1/20 0.54
▸ NPY2R P49146 7/20 0.53
▸ NPY4R P50391 7/20 0.53
▸ NPY5R Q15761 7/20 0.53
▸ NPY1R P25929 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31415949 0.93 SLC6A2 (0.63) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL38663397 0.93 NPY2R (0.56) SLC6A2NTSR2NTSR1SORT1NPY2R
SCHEMBL31694376 0.87 SLC6A2 (0.65) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL29418159 0.87 SLC6A2 (0.64) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL32677402 0.86 OPRM1 (0.61) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL29463750 0.86 CALCR (0.57) NTSR2NTSR1SORT1OPRM1NPY2R
SCHEMBL32670304 0.85 SLC6A2 (0.54) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL31307249 0.85 SLC6A2 (0.66) SLC6A2NTSR2NTSR1SORT1OPRM1
SCHEMBL29940473 0.85 NTSR1 (0.64) NTSR2NTSR1SORT1OPRM1NPY1R
SCHEMBL31255817 0.84 SLC6A2 (0.56) SLC6A2NTSR2NTSR1SORT1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002590-A1 TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS UNIWERSYTET GDÁNSKI (PL) 2025-01-02 — — WO claimed
EP-4484954-A1 MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES Uniwersytet Gdanski (PL) 2025-01-01 — — EP claimed
WO-2025002590-A1 TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS UNIWERSYTET GDÁNSKI (PL) 2025-01-02 — — WO disclosed
EP-4484954-A1 MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES Uniwersytet Gdanski (PL) 2025-01-01 — — EP disclosed
EP-4484955-A1 METHOD FOR SCREENING OF EXTRACELLULAR TISSUE PEPTIDES IN MAMMALIAN TISSUE SAMPLES FOR HEALTH STATUS EVALUATION, DISEASE DIAGNOSTICS AND NEOANTIGEN DISCOVERY Uniwersytet Gdanski (PL) 2025-01-01 — — EP disclosed
Send feedback